Quest Diagnostics Inc  

(Public, NYSE:DGX)   Watch this stock  
Find more results for DGX
-0.02 (-0.03%)
Jan 30 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 70.31 - 72.63
52 week 50.46 - 72.63
Open 70.31
Vol / Avg. 2.30M/1.48M
Mkt cap 10.27B
P/E 18.81
Div/yield 0.38/2.14
EPS 3.78
Shares 144.00M
Beta 0.77
Inst. own 104%
Apr 22, 2015
Q1 2015 Quest Diagnostics Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jan 29, 2015
Q4 2014 Quest Diagnostics Inc Earnings Release
Jan 29, 2015
Q4 2014 Quest Diagnostics Inc Earnings Call - Webcast
Jan 14, 2015
Quest Diagnostics Inc at JPMorgan Healthcare Conference
Jan 6, 2015
Quest Diagnostics Inc at Goldman Sachs CEOs Unscripted Healthcare Conference
Dec 2, 2014
Quest Diagnostics at Piper Jaffray Healthcare Conference - Webcast
Nov 5, 2014
Quest Diagnostics Inc INvestor Day
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 10.36% 7.90%
Operating margin 13.65% 13.22%
EBITD margin - 17.44%
Return on average assets 7.95% 6.24%
Return on average equity 17.49% 13.31%
Employees 41,000 -
CDP Score - 59 D


3 Giralda Farms
United States - Map
+1-973-5202700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Quest Diagnostics Incorporated (Quest Diagnostics) is a provider of diagnostic testing, information and services, providing insights that enable patients and physicians to make healthcare decisions. Quest Diagnostics offers United States patients and physicians the access to diagnostic testing services through its nationwide network of laboratories and Company-owned patient service centers. The Company provides interpretive consultation through the medical and scientific staff. The Company is a provider of clinical testing, including gene-based and esoteric testing and anatomic pathology services, and the provider of risk assessment services for the life insurance industry. The Company also is a provider of testing for clinical trials and testing for drugs of abuse. In April 2014, the Company announced the acquisition of Summit Health. Combined business will be referred to as Quest Diagnostics Health and Wellness Services.

Officers and directors

Stephen H. Rusckowski President, Chief Executive Officer, Director
Age: 56
Bio & Compensation  - Reuters
Mark J. Guinan Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Lidia L. Fonseca Senior Vice President, Chief Information Officer
Age: 44
Bio & Compensation  - Reuters
Michael E. Prevoznik Senior Vice President, General Counsel
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Jon Roger Cohen M.D. Senior Vice President, Chief Medical Officer
Age: 59
Bio & Compensation  - Reuters
Everett V. Cunningham Senior Vice President - Commercial
Age: 47
Bio & Compensation  - Reuters
James E. Davis Senior Vice President - Operations
Age: 51
Bio & Compensation  - Reuters
Catherine T. Doherty Senior Vice President - Clinical Franchises
Age: 51
Bio & Compensation  - Reuters
Franklin R. Cockerill III, M.D. Vice President & Chief Laboratory Officer
Bio & Compensation  - Reuters
Daniel C. Stanzione Ph.D. Non-Executive Chairman of the Board
Age: 68
Bio & Compensation  - Reuters